Bioaerosol Science

Device Challenge Aerosol

Challenge detectors and mitigation systems with controlled bioaerosol or tracer releases across wide concentration ranges.

We generate repeatable aerosols, control airflow, RH, and temperature, and quantify reference samples with qPCR, ddPCR, or fluorescence.

ISO 17025ASTM F2101ASTM F2299EN 149Reviewed 2026-05-16
Request a quoteSubmit a sample

Purpose & when to use

Device Challenge Aerosol testing exposes sensors, collectors, respiratory-protection products, and mitigation devices to controlled biological or particle-tracer aerosols. Collison nebulizers, airflow control, environmental logging, and qPCR, ddPCR, or fluorescence quantitation create a reference challenge concentration under ISO 17025 controls, with method choices aligned to ASTM, EN, or 42 CFR frames when device class requires them:

  1. Bioaerosol detector sensitivity mapping for fixed or fieldable instruments, using Collison-generated targets and ISO 17025 reference sampling to define detection limits.
  2. Respiratory-protection product comparisons under ASTM F2299, EN 149, or 42 CFR Part 84 context, using particle counters and tracer aerosols to map penetration and response.
  3. Medical-mask or barrier-device challenge studies aligned to ASTM F2101 or EN 14683, using biological or fluorescent tracers to compare capture performance.
  4. Air-treatment and collector validation under ISO 17025 controls, using chamber or duct releases with reference impingers, filters, and qPCR or ddPCR quantitation.
  5. Alert-logic and false-alarm evaluation for bioaerosol sensors, using defined backgrounds, blanks, and replicate release sequences within an ISO 17025 quality system.

Use this service when a device must respond to a defined aerosol challenge rather than a nominal specification. The study plan sets the target, background, flow field, and reference recovery workflow before method selection.

Built for detectors, collectors, and protection devices

Device challenge aerosol studies span products that sense, capture, filter, or reduce bioaerosols and particle tracers. The setup adapts to ISO, ASTM, EN, or 42 CFR expectations without treating every device as the same fixture.

  • DetectorsBioaerosol sensors and alarms
  • CollectorsSamplers and capture devices
  • RespiratorsFiltering facepiece programs
  • Medical masksBarrier and BFE studies
  • Air cleanersRoom and duct mitigation

Instrumentation & measurement ranges

Challenge design follows the target aerosol, device inlet geometry, environmental sensitivity, and reference quantitation endpoint.

1 - 1000 L/minchallenge-flow

Collison and related nebulizers

Generate controlled biological, surrogate, or particle-tracer aerosols into a chamber, duct, or device inlet with release rate documented for each condition.

20 - 80 RHcondition-control

Environmental and airflow control

Flow, temperature, and relative humidity are logged through each challenge so detector response and recovery can be interpreted against the exposure environment.

0.5 - 30 L/minsampler-flow

Inline reference samplers

Impingers, filter holders, or capture trains collect reference aerosol at defined locations and intervals for recovery, blanks, and concentration calculation.

10 - 100000000 copiesquantitation

qPCR, ddPCR, and fluorescence endpoints

Biological and fluorescent tracer quantitation converts collected challenge material into reference concentration, recovery, and dose-response inputs.

Test method options

MethodStrengthsTradeoffAligned with
Detector dose-response mapping
  • Defines limit of detection, response curve, and usable alert threshold for bioaerosol detectors under ISO 17025 records.
  • Pairs device output with reference sampler recovery so algorithm tuning is based on measured challenge concentration.
Requires multiple concentrations, blanks, and replicates, so test time grows with each target organism or surrogate.
ISO 17025
Respiratory-protection particle challenge
  • Supports respirator and filtration-media comparisons using ASTM F2299, EN 149, or 42 CFR Part 84 aerosol challenge context.
  • Reports penetration or device response alongside pressure, flow, and environmental records for design or supplier decisions.
Fixture sealing, face velocity, and challenge aerosol selection must be locked before data can be compared across products.
ASTM F2299EN 14942 CFR Part 84
Medical-barrier bioaerosol challenge
  • Aligns medical mask and barrier-device studies to ASTM F2101 or EN 14683 bacterial filtration efficiency context.
  • Uses biological or fluorescent tracers with reference samplers to compare capture performance, breakthrough, or device response.
Method fit depends on product geometry and claim language; non-mask devices often need a documented adaptation rationale.
ASTM F2101EN 14683

Setup configurations

Every device challenge starts with the aerosol target, device placement, and decision threshold. The configuration defines release location, mixing strategy, reference sampler positions, environmental setpoints, replicate logic, device settings, and data-capture responsibilities before the first challenge run. These dimensions are documented in the study plan:

Device interfaces

Device-under-test placement in a chamber, duct, fixture, or inlet adapter with geometry photographed and recorded.

Flow & actuation profiles

Defined challenge airflow, device operating mode, and release timing; detector sampling cadence and internal logs captured when available.

Environmental controls

Temperature, RH, and background aerosol conditions logged before, during, and after each challenge sequence.

Sample numbers

Replicate challenges per condition plus blanks, background runs, and device-off controls sized to the decision risk.

Calibration & verification

Sampler flow, nebulizer output checks, assay controls, and environmental sensors verified within the study record.

Methods anchored to the standards that matter

The quality frame follows the device class and decision. ISO 17025 is the accredited laboratory anchor; ASTM, EN, and 42 CFR frames are applied as aligned methods where the product and claim support them.

  • ISO 17025AccreditedTesting-laboratory competence, traceable records, calibration control, and uncertainty contributors.
  • ASTM F2101AlignedBacterial filtration efficiency context for medical mask and barrier-device challenges.
  • ASTM F2299AlignedParticle penetration context for respirator media and filtration comparisons.
  • EN 149AlignedEuropean filtering half-mask context for aerosol penetration and classification studies.

Key data outputs & reporting

Device challenge aerosol reports connect the device response to a measured reference challenge, not just the generator setting. Outputs include concentration estimates, response timing, alert calls, recovery checks, environmental logs, and the QA / QC records needed to explain where the data are comparable, where they are fit for purpose, and how each conclusion was reached.

Primary outputs

  • Dose-response summary showing device signal, alert state, or capture result versus measured reference concentration.
  • Time-to-detect and alert-rate tables, including true positive, false positive, and false negative counts when the device output supports classification.
  • Reference sampler recovery, background, and blank results with qPCR, ddPCR, fluorescence, or particle-count endpoint details.
  • Environmental and flow logs tied to each challenge sequence, including RH, temperature, airflow, release timing, and device operating mode.

Deliverables

#FormatContents
01PDF reportMethods, controls, challenge conditions, response summaries, and conclusions.
02CSV / XLSX datasetsTime series, reference concentrations, alert calls, sampler recovery, and environmental logs.
03FiguresDose-response plots, time-to-detect distributions, and annotated challenge timelines.

QA / QC & data integrity

Challenge studies run with a documented QA / QC envelope sized to the aerosol target, device class, and quantitation endpoint. Controls separate true device response from background, sampler recovery, assay variability, and environmental drift. Records are maintained under the ISO 17025 quality system from sample receipt through final report.

Reference sampler blanks, background runs, and device-off controls included with every challenge sequence.

Replicate challenge runs and repeated sequences quantify run-to-run variability and response reliability.

Recovery verification for impingers, filters, extraction steps, and tracer assays where applicable.

Calibration and verification records for sampler flow, airflow, RH, temperature, and quantitation instruments.

Chain of custody for organisms, tracers, devices, collected samples, and extracted materials.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)
17025Accredited testing
900+Studies Performed
17+Years in operation
300+Clients supported

Common questions

Quick answers to the questions bioaerosol detector teams, air-treatment developers, respiratory-protection programs, and medical-device teams ask when scoping a device challenge aerosol study. Topics include surrogate selection, concentration range, controls, time-to-detect outputs, applicable standards, reference quantitation, and deliverable formats. Reach out if your device geometry, target aerosol, or regulatory frame does not match the examples below.

Q.Can you challenge with non-viable surrogates?
A.Yes. Fluorescent or biological tracers are common when viability is not required. We choose the surrogate based on the device response mechanism, biosafety requirements, and reference quantitation endpoint.
Q.How do you define the challenge concentration range?
A.We bracket the expected detection threshold, then add points above and below it to build a response curve. Background level, sampling volume, and assay sensitivity set the practical range.
Q.Do you provide ROC and time-to-detect metrics?
A.Yes, when the device output supports classification. We can summarize time-to-detect, alert rate, sensitivity, false positives, and false negatives against measured reference concentrations.
Q.What controls are included?
A.Typical controls include device-off baselines, sampler blanks, background runs, and replicate challenge sequences. Recovery checks are added for impingers, filters, extraction steps, and tracer assays.
Q.Which standards apply to my device?
A.The product category drives the frame. Respirators may point to EN 149 or 42 CFR Part 84, medical masks to ASTM F2101 or EN 14683, and sensor studies to ISO 17025 records.

Standards & guidance

Device challenge aerosol studies are planned around the standard that matches the product and decision. ISO 17025 is the accredited laboratory anchor. ASTM F2101, ASTM F2299, EN 14683, EN 149, and 42 CFR Part 84 are aligned frames used where the device class, aerosol type, and claim language support them.

QA & Regulatory - Accredited

ISO 17025

Testing-laboratory competence, documented methods, calibration traceability, uncertainty, and data reviewView standard ->Bioaerosol & Barrier Devices - Aligned

ASTM F2101

Bacterial filtration efficiency context for medical face masks and barrier materialsView standard ->Respiratory Protection - Aligned

ASTM F2299

Particle penetration by latex spheres for respirator and barrier-material comparisonsView standard ->Medical Devices - Aligned

EN 14683

Medical face mask performance context, including bacterial filtration efficiencyView standard ->Respiratory Protection - Aligned

EN 149

Filtering half-mask aerosol penetration and classification context for respiratory protectionView standard ->Respiratory Protection - Aligned

42 CFR Part 84

NIOSH respirator approval context for particulate filter efficiency and resistanceView standard ->

Related services & devices

Service

Bioaerosol Efficacy Testing (Room)

Pairs chamber challenge design with reduction metrics for room-scale air treatment and mitigation claims.Read more ->Devices

Respiratory

Masks, respirators, PAP devices, and anesthesia systems that need aerosol challenge, penetration, or barrier-performance data.Read more ->Service

Particle & Gas Sensor Validation

Complements biological challenge work with particle and gas sensor response, drift, and false-alarm characterization.Read more ->Devices

Air Treatment

Portable, in-duct, UVGI, and hybrid air-cleaning devices challenged with defined aerosol releases.Read more ->